Hartmut Timmermann

Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study

David J. Jackson, Liam G. Heaney, Marc Humbert et al. · The Lancet · 2023 · 139 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +14

Response to Biologics and Clinical Remission in the Adult German Asthma Net Severe Asthma Registry Cohort

Katrin Milger, Hendrik Suhling, Dirk Skowasch et al. · The Journal of Allergy and Clinical Immunology In Practice · 2023 · 86 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +14

Frequent productive cough: Symptom burden and future exacerbation risk among patients with asthma and/or COPD in the NOVELTY study

Rod Hughes, Eleni Rapsomaniki, Christer Janson et al. · Respiratory Medicine · 2022 · 44 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +15

Prevalence of Patients with Uncontrolled Asthma Despite NVL/GINA Step 4/5 Treatment in Germany

Karl‐Christian Bergmann, Dirk Skowasch, Hartmut Timmermann et al. · Journal of Asthma and Allergy · 2022 · 34 citations · Full text

Medicine, Health Sciences, Internal Medicine +14

The German severe asthma patient: Baseline characteristics of patients in the German Severe Asthma Registry, and relationship with exacerbations and control

Stephanie Korn, Katrin Milger, Dirk Skowasch et al. · Respiratory Medicine · 2022 · 30 citations

Medicine, Internal Medicine, Clinical Epidemiology +11